mAbs · 2021 · 37 citations · 45 references
PharmacyBiotechnologyImmunologyAntibody EngineeringMolecular VirologyVirologyAntibody DiscoveryAntibody Fragment EngineeringAntibody Specificity EngineeringAntibody StructureAntibody-antigen RecognitionBispecific AntibodiesAntibody-mediated Viral NeutralizationAntigen-binding FragmentsBispecific Antibody CombinationsBispecific Antibody ConjugatesBispecific Antibody DiscoveryBispecific Antibody FragmentsSars-cov-2 InfectionViral Receptor Binding Domains
Numerous neutralizing antibodies that target SARS-CoV-2 have been reported, and most directly block binding of the viral Spike receptor-binding domain (RBD) to angiotensin-converting enzyme II (ACE2). Here, we deliberately exploit non-neutralizing RBD antibodies, showing they can dramatically assist in neutralization when linked to neutralizing binders. We identified antigen-binding fragments (Fabs) by phage display that bind RBD, but do not block ACE2 or neutralize virus as IgGs. When these non-neutralizing Fabs were assembled into bispecific VH/Fab IgGs with a neutralizing VH domain, we observed a ~ 25-fold potency improvement in neutralizing SARS-CoV-2 compared to the mono-specific bi-valent VH-Fc alone or the cocktail of the VH-Fc and IgG. This effect was epitope-dependent, reflecting the unique geometry of the bispecific antibody toward Spike. Our results show that a bispecific antibody that combines both neutralizing and non-neutralizing epitopes on Spike-RBD is a promising and rapid engineering strategy to improve the potency of SARS-CoV-2 antibodies.
45
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp, Nianshuang Wang, Kizzmekia S. Corbett et al. · Science · 2020 · 9.8K citations · Full text
Compassionate Use of Remdesivir for Patients with Severe Covid-19
Jonathan Grein, Norio Ohmagari, Daniel D. Shin et al. · New England Journal of Medicine · 2020 · 2.9K citations · Full text
Vanessa Monteil, Hyesoo Kwon, Patricia Prado et al. · Cell · 2020 · 2.3K citations · Full text
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto, Young‐Jun Park, Martina Beltramello et al. · Nature · 2020 · 2.2K citations · Full text
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani, Christian Gaebler, Frauke Muecksch et al. · Nature · 2020 · 2.1K citations · Full text